Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ceftezole is an α-Glucosidase inhibitor (IC50: 2.1 μM; Ki: 0.578 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Ceftezole is an α-Glucosidase inhibitor (IC50: 2.1 μM; Ki: 0.578 μM). |
Targets&IC50 | α-glucosidase:(ki)0.578 μM , α-glucosidase:2.1 μM |
In vivo | In vivo streptozotocin-induced mouse model, blood glucose levels are decreased by 30% 20 min after Ceftezole treatment (10 mg/kg/day). Expression levels of GSK-3, peroxisome proliferator-activated receptor-γ, and uncoupling protein-3 mRNA are also slightly decreased compared to controls following Ceftezole treatment. |
Molecular Weight | 437.52 |
Formula | C16H15N5O4S3 |
CAS No. | 65307-12-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cefetrizole 65307-12-2 Metabolism Glucokinase inhibitor inhibit